Silymarin Administration Attenuates Cirrhotic-induced Cardiac Abnormality in the Rats: A Possible Role of β1-adrenergic Receptors and L-type Voltage-Dependent Calcium Channels
Background: Cirrhotic cardiomyopathy is a well-recognized cardiac dysfunction in cirrhotic patients. Studies have confirmed the protective effects of silymarin in different types of cardiac injury. This study aimed to examine the effectiveness and molecular mechanism of silymarin against myocardial...
Main Authors: | Gholamreza Bayat, Roham Mazloom, Seyed Ali Hashemi, Khalil Pourkhalili, Parviz Fallah, Alireza Shams, Parvaneh Esmaeili, Azadeh Khalili |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2022-07-01
|
Series: | Iranian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ijms.sums.ac.ir/article_48131_7e100372dc83344c396c029e6a28b4b0.pdf |
Similar Items
-
Biliary cirrhosis-induced cardiac abnormality in rats: Interaction between Farnesoid-X-activated receptors and the cardiac uncoupling proteins 2 and 3
by: Gholamreza Bayat, et al.
Published: (2022-01-01) -
The impact of Silymarin on improvement of platelet abnormalities in patients with severe preeclampsia
by: Fahimeh Kaveh Baghbahadorani, et al.
Published: (2016-05-01) -
A Comparison of QTc Abnormalities in Cirrhotics with Non-Cirrohotic
by: M Mujtaba Ali, et al.
Published: (2020-12-01) -
The Impact of Silymarin on Improvement of Hepatic Abnormalities in Patients with Severe Preeclampsia: A Randomized Clinical Trial
by: Fahimeh Kaveh Baghbahadorani, et al.
Published: (2017-08-01) -
Cirrhotic Cardiomyopathy
by: Kieran Longley, et al.
Published: (2021-02-01)